HK Stock MarketDetailed Quotes

02179 RECBIO-B

Watchlist
  • 9.800
  • -0.060-0.61%
Market Closed Mar 28 16:08 CST
4.73BMarket Cap-7498P/E (TTM)

About RECBIO-B Company

Jiangsu Ruike Biotechnology Co., Ltd. (“Ricoh Biotech” or the “Company”) is an innovative vaccine company committed to developing and commercializing safer and more effective innovative vaccines to address public health needs that are far from being met. Ricoh Biotech has high-value vaccine packages and is driven by self-developed novel adjuvant technology and protein engineering technology. Through the company's strong R&D capabilities, a powerful innovative vaccine portfolio composed of 11 vaccine candidates has been established, and coverage has been strategically expanded to include 5 of the 10 most burdensome diseases in the “Global Burden of Disease” assessed by DALYs published by the World Health Organization in 2019, and the disease fields covered by 3 of the 5 best-selling vaccine products in the world in 2020. Currently, the company's core product, REC603, a recombinant HPV nine-valent vaccine, is in phase III clinical trials. The company has formulated a clear commercialization strategy in China and overseas with the aim of further penetrating diversified markets around the world. At the same time, the company has developed three advanced technology platforms for novel adjuvant development, protein engineering, and immune evaluation. These platforms enable companies to continuously discover and develop innovative vaccines and apply advanced technology to vaccine candidates. The company completed Series A financing in 2019, Series B financing in 2020, and completed Series B+ financing and Series C financing in 2021, respectively.

Company Profile

Symbol02179
Company NameRECBIO-B
ISINCNE1000057K9
Listing Date03/31/2022
Issue Price24.80
Shares Offered30.85M share
Founded05/18/2012
RegistrationChina
ChairmanYong Liu
SecretaryQingqing\heyanqun Chen
Audit InstitutionErnst & Young
Company CategoryMainland registration of Mainland Individuals control
Registered OfficeNo. 888, Yaocheng Avenue, Taizhou Pharmaceutical High-tech Zone
Head Office and Principal Place of Business40th Floor, Dah Sing Financial Centre, 248 Queen's Road East, Wan Chai, Hong Kong
Fiscal Year Ends12-31
Employees472
MarketHong Kong motherboard
Phone(0523)88820888
Fax(86)(523)86818860
Emailmedia@recbio.cn
Business Jiangsu Ruike Biotechnology Co., Ltd. is a Chinese company engaged in vaccine research and development. The company has a range of clinical and preclinical vaccines. The human papillomavirus (HPV) vaccine pipeline includes the recombinant HPV nine-valent vaccine candidate REC603, the recombinant HPV bivalent vaccine candidate REC601 and REC602, the recombinant HPV quadrivalent vaccine Rec604a, and the recombinant HPV nine-valent vaccine Rec604b. The company is also involved in the development of a COVID-19 vaccine. The company mainly sells its products in the domestic market.

Company Executives

  • Name
  • Position
  • Salary
  • Yong Liu
  • Executive Director,Nomination Committee Chairman,Chairman of the Board,GM,Authorized Representative
  • --
  • Jianping Chen
  • Deputy GM,Executive Director
  • --
  • Bu Li
  • Remuneration Committee Member,Deputy GM,Executive Director,Authorized Representative
  • --
  • Kunxue Hong
  • Non-Executive Director
  • --
  • Hongbin Zhou
  • Audit Committee Member,Non-Executive Director
  • --
  • Houwei Hu
  • Non-Executive Director
  • --
  • Guodong Liang
  • Nomination Committee Member,Independent Non-Executive Director,Remuneration Committee Member
  • --
  • Lijun Xia
  • Remuneration Committee Member,Audit Committee Chairman,Independent Non-Executive Director,Nomination Committee Member
  • --
  • GAO Feng
  • Independent Non-Executive Director,Nomination Committee Member,Remuneration Committee Member
  • --
  • Minghui Yuan
  • Remuneration Committee Chairman,Independent Non-Executive Director,Audit Committee Member
  • --
  • Weiwei Qiao
  • Chairman of the Supervisory Board
  • --
  • Feizhou Wang
  • Supervisor
  • --
  • Ranting Qian
  • Supervisor
  • --
  • Ping Liu
  • Employee representative supervisor
  • --
  • Hongjun Zhou
  • Deputy GM
  • --
  • Qingqing Chen
  • Joint Company Secretary,Deputy GM,Company Secretary,Executive Director,CFO
  • --
  • Lei Zhou
  • Finance Director
  • --
  • Yanqun He
  • Legal Proceedings Documents Agent,Joint Company Secretary
  • --
  • Jiaxin Zhang
  • Non-Executive Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg